DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the market capitalisation of Indrayani Biotech Ltd?

Indrayani Biotech Ltd has a market capitalisation of approximately ₹63 crore.

Indrayani Biotech Ltd

INDRAYANIBIOTECHLTD·NSE·FMCG

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

FMCG · Agricultural Products

Carries meaningful debt — watch the balance sheet

52W₹7

₹18-59%

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

₹63 Cr

P/E Ratio

N/A

P/B Ratio

0.49

EPS

₹-0.78

Book Value

₹15.96

ROE

-6.11%Weak

ROCE

3.00%Weak

Dividend Yield

0.00%

Debt / Equity

1.88High

Face Value

₹10.00

52W High

₹18.08

52W Low

₹6.69

Sector

FMCG

Industry

Agricultural Products

Expensive

None moatHigh uncertainty

Fair value estimate

₹12

No recent traded price

BearFair valueBull

₹10₹12₹14

/100

Business quality — Watch the fundamentals

Growth 50Profitability 0Efficiency 0Valuation 6

Plain English

Our view

Carries meaningful debt — watch the balance sheet
High leverage — debt exceeds 1.5× equity

Risks

High leverage — debt exceeds 1.5× equity
Weak returns on equity (-6%)

How we got there

Fair value methods

Residual income

-9% ROE fading to 14% over ~3 yrs, on ₹16 book

₹12

Relative P/E

Needs positive EPS

—

Graham floor

Needs positive EPS

—

Analyst target

No analyst coverage

—

Blended fair value₹12

What the numbers say

Investment thesis

Bull case

No standout positives from the current metrics.

Bear case

High leverage — debt exceeds 1.5× equity
Weak returns on equity (-6%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

-6.1%Weak

Above 15% is considered healthy for Indian equities

ROCE

3.0%Weak

Above 18% means capital is working hard

Debt/Eq

1.88High

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹63 Cr

P/B

0.49

EPS

₹-0.78

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

N/A

No history

Profitability

Loss-making

-6.1% ROE

Financial health

Leveraged

D/E 1.88

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Pros

Stock is trading at 0.82 times its book value
Company is expected to give good quarter

Watch-outs

Cons

Company has low interest coverage ratio.
Promoter holding is low: 33.3%
Company has a low return on equity of 5.79% over last 3 years.
Earnings include an other income of Rs.6.47 Cr.
Company has high debtors of 165 days.
Promoter holding has decreased over last 3 years: -11.6%
Working capital days have increased from 114 days to 211 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

33%

Promoter

Promoters

33.3%0.00

Public

49.0%+0.55

FII / FPI

0.0%0.00

DII

3.1%0.00

Others

14.6%

Total shareholders

25,509-56 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter33.26%

DII3.13%

Public48.99%

Others14.62%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]